In GC, it has been shown that patients with high biglycan levels are associated with high tumor stages, vessel invasion, the presence of lymph node metastasis, and poor overall survival [28,29]. The gene discussed is BGN; the disease is metastatic malignant neoplasm in the lymph nodes.